ReviewInnere Medizin (Heidelberg, Germany)2026
[Echocardiography in cardiology-Basic tool, current developments and future perspectives].
Review in Innere Medizin (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite advances in computed tomography (CT) and magnetic resonance imaging (MRI), transthoracic echocardiography remains the central imaging method in cardiology and internal medicine. Key advantages are ubiquitous availability, repeatability and the direct linkage between findings and symptoms at the bedside. In daily practice it answers questions relevant to treatment with respect to pump function, pericardial effusion or tamponade, relevant valvular diseases, heart failure with preserved ejection fraction (HFpEF), pulmonary hypertension and the hemodynamic profile in shock, sepsis or circulatory instability. A prerequisite for reliable diagnostics is a standardized, guideline-conform examination. In valvular diseases, the goal is not only the detection but also the precise quantification of the disease and assessment of the treatment urgency. This particularly applies to challenging constellations, such as the frequently underestimated low-flow low-gradient aortic valve stenosis. In the acute setting, focused cardiac ultrasound can provide a rapid orientation but it does not replace a complete transthoracic examination. The limitations of the method reside less in the technique itself than in insufficient standardization, misapplication and poor image quality. Current and future developments will further enhance the diagnostic value. Examples are artificial intelligence (AI)-assisted assessment with automated analysis of various parameters, pattern recognition for disease detection, speckle tracking strain and accompanying refinements, left atrial strain for advanced assessment of the diastolic function, 3D echocardiography, and shear wave imaging for estimating myocardial stiffness. Echocardiography thus remains an indispensable, dynamic and effective method. Critical factors are standardized workflows, guideline-conform quantification and the interpretation of findings within the clinical context.
Indexed as
Identifiers
42728390What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.